The methods disclosed herein relate to the treatment of chronic dermal disorders, such as for example atopic dermatitis or psoriasis, in human patients, by orally or topically administering a therapeutically effective amount of RS-norketotifen. Therapeutic antimicrobial activity of RS-norketotifen against